Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The AZITRAMBA Trial
NCT03736629Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- Feb 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in asthma (3 arms), sponsored by University of Chicago. Primary endpoint: Asthma Control Test Score Change From Baseline at 8 weeks. Started Feb 2019; status: terminated.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03736629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03736629.